Somatostatin receptors in the nucleus accumbens modulate dopamine-dependent but not acetylcholine-dependent turning behaviour of rats

Neuroscience

Volumn 159, Issue 3, 2009, Pages 974-981

  Ikeda, H ^a   Kotani, A ^a   Koshikawa, N ^a   Cools, A R ^b  

^a NIHON UNIVERSITY   (Japan)

^b RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

Author keywords

dopamine receptors; nucleus accumbens; rats; somatostatin receptors; turning behaviour

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; ACETYLCHOLINE; CARBACHOL; CYCLOSOMATOSTATIN; DOPAMINE; QUINPIROLE; SOMATOSTATIN; SOMATOSTATIN DERIVATIVE; SOMATOSTATIN RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CHOLINERGIC SYSTEM; CIRCLING BEHAVIOR; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; INJECTION; MALE; NERVE STIMULATION; NEUROMODULATION; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; RAT;

2,3,4,5-TETRAHYDRO-7,8-DIHYDROXY-1-PHENYL-1H-3-BENZAZEPINE; ACETYLCHOLINE; ANIMALS; CARBACHOL; CHOLINERGIC AGONISTS; DOPAMINE; DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; HORMONES; MALE; MOTOR ACTIVITY; NUCLEUS ACCUMBENS; PEPTIDES, CYCLIC; QUINPIROLE; RATS; RATS, WISTAR; RECEPTORS, SOMATOSTATIN; SOMATOSTATIN; SPATIAL BEHAVIOR;

EID: 62249087070     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2009.01.053     Document Type: Article

References (50)

1. B receptors in the nucleus accumbens shell differentially modulate dopamine and acetylcholine receptor-mediated turning behaviour. Neuropharmacology 46 (2004) 1082-1088
2. 2 receptors in rat nucleus accumbens: resistance to differential rearing conditions. Neuroscience 45 (1991) 281-290
3. Beal M.F., Domesick V.B., and Martin J.B. Regional somatostatin distribution in the rat striatum. Brain Res 278 (1983) 103-108
4. Beal M.F., and Martin J.B. Effects of neuroleptic drugs on brain somatostatin-like-immunoreactivity. Neurosci Lett 47 (1984) 125-130
5. Berendse H.W., Groenewegen H.J., and Lohman A.H. Compartmental distribution of ventral striatal neurons projecting to the mesencephalon in the rat. J Comp Neurol 12 (1992) 2079-2103
6. Brazeau P., Vale W., Burgus R., Ling M., Butcher J., Rivier J., and Guillemin R. Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science 179 (1973) 77-79
7. Brownstein M., Arimura A., Sato H., Schally A.V., and Kizer J.S. The regional distribution of somatostatin in the rat brain. Endocrinology 96 (1975) 1456-1461
8. Chesselet M.F., and Reisine T.D. Somatostatin regulates dopamine release in rat striatal slices and cat caudate nuclei. J Neurosci 3 (1983) 232-236
9. Deutch A.Y., and Cameron D.S. Pharmacological characterization of dopamine systems in the nucleus accumbens core and shell. Neuroscience 46 (1992) 49-56
10. Eve D.J., Nisbet A.P., Kingsbury A.E., Temlett J., Marsden C.D., and Foster O.J. Selective increase in somatostatin mRNA expression in human basal ganglia in Parkinson's disease. Brain Res Mol Brain Res 50 (1997) 59-70
11. Feifel D., and Minor K.L. Cysteamine blocks amphetamine-induced deficits in sensorimotor gating. Pharmacol Biochem Behav 58 (1997) 689-693
12. Hathway G.J., Emson P.C., Humphrey P.P.A., and Kendrick K.M. Somatostatin potently stimulate in vivo striatal dopamine and γ-aminobutyric acid release by a glutamate-dependent action. J Neurochem 70 (1998) 1740-1749
13. 2 receptors mediate striatal dopamine release. Br J Pharmacol 128 (1999) 1346-1352
14. Hathway G.J., Humphrey P.P.A., and Kendrick K.M. Somatostatin induces striatal dopamine release and contralateral turning behaviour in the mouse. Neurosci Lett 358 (2003) 127-131
15. Hoyer D., Bell G.I., Berelowitz M., Epelbaum J., Feniuk W., Humphrey P.P.A., O'Carroll A.M., Patel Y.C., Schonbrunn A., Taylor J.E., and Reisine T. Classification and nomenclature of somatostatin receptors. Trends Pharmacol Sci 16 (1995) 86-88
16. Heimer L., Zahm D.S., Churchill L., Kalivas P.W., and Wohltmann C. Specificity in the projection patterns of accumbal core and shell in the rat. Neuroscience 41 (1991) 89-125
17. Ikeda H., Akiyama G., Fujii Y., Minowa R., Koshikawa N., and Cools A.R. Role of AMPA and NMDA receptors in the nucleus accumbens shell in turning behaviour of rats: interaction with dopamine receptors. Neuropharmacology 44 (2003) 81-87
18. A receptors in the pedunculopontine tegmental nucleus play a crucial role in rat shell-specific dopamine-mediated, but not shell-specific acetylcholine-mediated, turning behaviour. Neuroscience 125 (2004) 553-562
19. Ikeda H., Moribe S., Sato M., Kotani A., Koshikawa N., and Cools A.R. Adrenergic receptors in the nucleus accumbens shell differentially modulate dopamine and acetylcholine receptor-mediated turning behaviour. Eur J Pharmacol 554 (2007) 175-182
20. 2-receptor agonist and antagonist drugs on somatostatin binding, inhibition of adenylyl cyclase activity and accumulation of inositol 1,4,5-trisphosphate in the rat striatum. Mol Brain Res 47 (1997) 99-107
21. Kitamura M., Koshikawa N., Yoneshige N., and Cools A.R. Behavioural and neurochemical effects of cholinergic and dopaminergic agonists administered into the accumbal core and shell in rats. Neuropharmacology 38 (1999) 1397-1407
22. A agents injected into the ventral pallidum differentially affect dopaminergic pivoting and cholinergic circling elicited from the shell of the nucleus accumbens. Neuroscience 104 (2001) 117-127
23. Koshikawa N. Role of the nucleus accumbens and the striatum in the production of turning behaviour in intact rats. Rev Neurosci 5 (1994) 331-346
24. 1 receptors in the nucleus accumbens of rats is due to stimulation of these receptors in the shell, but not the core, of this nucleus. Psychopharmacology 126 (1996) 185-190
25. Kotani A., Ikeda H., Koshikawa N., and Cools A.R. Role of orexin receptors in the nucleus accumbens in dopamine-dependent turning behaviour of rats. Neuropharmacology 54 (2008) 613-619
26. Lee N., Radke M., and Vincent S.R. Intra-cerebral cysteamine infusions attenuate the motor response to dopaminergic agonists. Behav Brain Res 29 (1988) 179-183
27. Lopez-Huerta V.G., Tecuapetla F., Guzman J.N., Bargas J., and Galarraga E. Presynaptic modulation of somatostatin in the neostriatum. Neurochem Res 33 (2008) 1452-1458
28. Lu J.Q., and Stoessl A.J. Somatostatin modulates the behavioural effects of dopamine receptor activation in parkinsonian rats. Neuroscience 112 (2002) 261-266
29. Martin J.L., Chesselet M.-F., Raynor K., Gonzales C., and Reisine T. Differential distribution of somatostatin receptor subtypes in rat brain revealed by newly developed somatostatin analogs. Neuroscience 41 (1991) 581-593
30. Martin-Iverson M.T., Radke J.M., and Vincent S.R. The effects of cysteamine on dopamine-mediated behaviours: evidence for dopamine-somatostatin interactions in the striatum. Pharmacol Biochem Behav 24 (1986) 1707-1714
31. Moribe S., Ikeda H., Sato M., Akiyama G., Matsuzaki S., Hasegawa K., Koshikawa N., and Cools A.R. Acetylcholine receptor effects on accumbal shell dopamine-mediated turning behaviour in rats. Neuropharmacology 49 (2005) 514-524
32. Norris P.J., Waldvogel H.J., Faull R.L., Love D.R., and Emson P.C. Decreased neuronal nitric oxide synthase messenger RNA and somatostatin messenger RNA in the striatum of Huntington's disease. Neuroscience 72 (1996) 1037-1047
33. Olias G., Viollet C., Kusserow H., Epelbaum J., and Meyerhof W. Regulation and function of somatostatin receptors. J Neurochem 89 (2004) 1057-1091
34. Palkovits M., Brownstein M.J., Eiden L.E., Beinfeld M.C., Russell J., Arimura A., and Szabo S. Selective depletion of somatostatin in rat brain by cysteamine. Brain Res 240 (1982) 178-180
35. Pallis E., Thermos K., and Spyraki C. Chronic desipramine treatment selectively potentiates somatostatin-induced dopamine release in the nucleus accumbens. Eur J Neurosci 14 (2001) 763-767
36. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates. 4th ed. (1998), Academic Press, San Diego
37. Rakovska A., Kiss J.P., Raichev P., Lazarova M., Kalfin R., and Milenov K. Somatostatin stimulates striatal acetylcholine release by glutamatergic receptors: an in vivo microdialysis study. Neurochem Int 40 (2002) 269-275
38. Rakovska A., Javitt D., Raichev P., Ang R., Balla A., Aspromonte J., and Vizi S. Physiological release of striatal acetylcholine (in vivo): effect of somatostatin on dopaminergic-cholinergic interaction. Brain Res Bull 61 (2003) 529-536
39. 1 receptors in the nucleus accumbens selectively mediate the stimulatory effect of somatostatin on locomotor activity in rats. J Pharmacol Exp Ther 265 (1993) 67-73
40. Rocheville M., Lange D.C., Kumar U., Patel S.C., Patel R.C., and Patel Y.C. Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity. Science 288 (2000) 154-157
41. Rodríguez-Sánchez M.N., Puebla L., López-Sañudo S., Rodríguez-Martín E., Martín-Espinosa A., Rodríguez-Pena M.S., Juarranz M.G., and Arilla E. Dopamine enhances somatostatin receptor-mediated inhibition of adenylate cyclase in rat striatum and hippocampus. J Neurosci Res 48 (1997) 238-248
42. Sagar S.M., Landry D., Millard W.J., Badger T.M., Arnold M.A., and Martin J.B. Depletion of somatostatin-like immunoreactivity in the rat central nervous system by cysteamine. J Neurosci 2 (1982) 225-231
43. Saigusa T., Koshikawa N., Kitamura M., Mizutani K., Kobayashi M., and Cools A.R. Dissimilarities between cholinergic and dopaminergic turning elicited by nucleus accumbens stimulation in freely moving rats. Eur J Pharmacol 274 (1995) 213-220
44. Szabo S., and Reichlin S. Somatostatin in rat tissues is depleted by cysteamine administration. Endocrinology 109 (1981) 2255-2257
45. Thermos K., Radke J., Kastellakis A., Anagnostakis Y., and Spyraki C. Dopamine-somatostatin interactions in the rat striatum: an in vivo microdialysis study. Synapse 22 (1996) 209-216
46. 1) modulates the release of somatostatin in the nucleus accumbens of the rat. Neuropharmacology 47 (2004) 612-618
47. Wightman R.M., Heien M.L.A.V., Wassum K.M., Sombers L.A., Aragona B.J., Khan A.S., Ariansen J.L., Cheer J.F., Phillips P.E.M., and Carelli R.M. Dopamine release is heterogeneous within microenvironments of the rat nucleus accumbens. Eur J Neurosci 26 (2007) 2046-2054
48. Zahm D.S., and Heimer L. Two transpallidal pathways originating in the rat nucleus accumbens. J Comp Neurol 302 (1990) 437-446
49. Zahm D.S., and Heimer L. Specificity in the efferent projections of the nucleus accumbens in the rat: comparison of the rostral pole projection patterns with those of core and shell. J Comp Neurol 327 (1993) 220-232
50. Zheng H., Bailey A., Jiang M.H., Honda K., Chen H.Y., Trumbauer M.E., Van der Ploeg L.H., Schaeffer J.M., Leng G., and Smith R.G. Somatostatin receptor subtype 2 knockout mice are refractory to growth hormone-negative feedback on arcuate neurons. Mol Endocrinol 11 (1997) 1709-1717